within Pharmacolibrary.Drugs.ATC.C;

model C02AC01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.75,
    Cl             = 0.0038333333333333336,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.0021000000000000003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Clonidine is a centrally acting alpha-2 adrenergic agonist commonly used for the treatment of hypertension and attention-deficit hyperactivity disorder (ADHD), and as adjunct therapy in opioid withdrawal and analgesia. It is approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>PK parameters reported for healthy adult subjects after single oral administration.</p><h4>References</h4><ol><li><a href='https://dx.doi.org/10.1007/BF00541193'>10.1007/BF00541193</a> Values reflect population mean as reported in 'Pharmacokinetics of clonidine in man' (S. Dahlstr√∂m et al., European Journal of Clinical Pharmacology, 1979). Some later studies show similar values for absorption and distribution. Bioavailability varies in published sources from 0.75 to 0.95.</li></ol></body></html>",
    revisions = "<html><body><ul><li>03/06/2025 model generated from PK parameters and knowledge obtained by LLM gpt-4.1 and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C02AC01;
